News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Best Assignment Help in Australia Online: TOP 5 Websites Reviews

Assignment Solutions

Realizing your potential largely hinges on how much you can identify your strengths, limits, creativity, weaknesses, turn-offs, and motivations. Once these things are settled, most things get into the right perspective. Assignment helps work the same way. Strengths, creativity, and interest often determine the result. Imagine the outcome if you have some assignments you are not motivated about. Or even with a burning interest, you just don’t have what it takes to do them. This could involve reasons like poor mastery of the English language, time constraints, lack of experience in the subject matter, etc. It becomes clear that as powerful as it is, interest is not enough to ascertain success in your academic pursuits. So, what happens then? You ask for the best assignment help. It is a legal and legitimate way of getting assignment help from experienced and expert writers who will set you on course for excellent grades in school. And if you are in Australia, this has been made a lot easier by having many reliable websites to get online assignment help. This does not have a restraint on your course of study. Thus, even if you are a student in the medical sciences in Australia, you could also get stuff like nursing assignment help from these sites. We have carefully curated this list just for you. Here are the best assignment help websites in Australia: PaperHelp - TOP rated assignment help website in Australia. 99Papers - the best essay writing service in Australia. PaperCoach - Melbourne company with the cheap instant assignment help. MyAssignmentHelp - popular assignment help provider to buy homework online. HomeworkForMe - highest quality college paper writers to hire in Sydney. Using these services would mean you have secured a successful academic story. Are you ready to read the full reviews of the best companies to help college students in Australia? Let's go! TOP 5 Australian Assignment Help Websites #1. PaperHelp PaperHelp came into the assignment help space several years back and stole the hearts of many students in Australia. Even till this very second, many candidates are on their websites reaching out to professional writers to help them craft a stellar piece that would give them an edge in their studies. And most of them are satisfied. That is why they keep coming back to buy essays from them. PaperHelp has a unique way of attracting students of all classes. Whether a high schooler, undergrad, or postgraduate student, all assignments are welcome and can be duly attended to on their website. Their website has been regarded as remarkably easy to use. The simplicity of the interface and seamless navigation make many students always go back to check them out, especially Australian high school and college students looking to woo their teachers in mid-term and subject take-home assignments. The website features a price calculator that helps you to track your fee as you order from them. Not only that, you can pick what category of academic difficulty your assignment is from and what type of writing it is – an essay, PowerPoint presentation, report, etc. On the same website, you get to pick the time you intend for the essay to be delivered. And once you have inputted all these, you will be directed to a proceed-to-order or checkout page where you make payments and set the ball of the assignment rolling for the writer. Another feature that makes their services unique is the quality of writers they have. Yes, their writers are some of the best in the entire market. That is, these folks are writing specialists who are ready to provide any assignment help you may require. They are mostly in academia and are alums of reputable universities globally. Thus, they can see through the right lenses to craft the best content in your essays and assignments. Their work is 100% plagiarism free and written from scratch. Thus, you do not have to worry about your supervisor, plagiarism checkers, or software flagging your assignments as copied. To cap it all up, PaperHelp respects deadlines. Thus, they deliver your assignments as and when they are due. So you can make it in time to submit your work. They are hands-ready to work on your paper and deliver it on time. If you are keen on getting a much shorter deadline than the one noted on their website, you might have to pay some extra fee. But you can rest assured that from $10, you would enjoy all the benefits their services offer on assignments. However, other things that could jerk up your total price tag on their site include add-ons like plagiarism reports, etc. PaperHelp customer review: “Excellent - I usually do not leave a review, but here I was pleasantly surprised. The guys really know their business. My order was completed on time, without any lexical or grammatical errors. Excellent, thank you for this order” – Bryden E. #2. 99Papers 99Papers is a great essay writing service in Australia. Many students fuss over the price of buying one assignment or college papers on their platform. But much more than that, they offer other things that endear many hearts to their website every day. And a major feature is that many services you could have bought separately on other platforms are offered freely on 99Papers. Examples include unlimited revision, plagiarism checks as well as proofreading. So, you do not have to get a heart skip because you might get overcharged on your first order with them. In fact, the exact opposite is what you should expect from them. You would enjoy top-grade content and delivery at a minimal price that would not negatively impact your wallet or purse. Now, you can be tempted to think that with the low price of $9.95 with 99Papers, then only lower difficulty level papers can be ordered from them. That's shortchanging yourself. They have a wide array of expert essay writers armed to the teeth with all it takes to give you an excellent delivery on any assignment you bring their way. Be it a high school essay or Master's level or Ph.D., are ably welcomed to be tended to. These writing specialists are English as Native Language (ENL) and English as Second Language (ESL) speakers and writers. Thus, if you are a student in Australia with a challenge of a good grasp of the English language, then these folks are ready to ease your struggles. By default, the ESL writers are the ones set to work on your paper. However, you can choose the ENL writer option. They are all experts in their field, so with their good command of the language, they can combine experience and expertise to craft the best assignment for you. With 99Paper's structure, you can contact writers directly and keep tabs on your work. And usually, you would be at rest even if you keep checking up on where the task is present. This is because they always deliver on time. They have a huge reverence for the deadline that the work is needed. So, they turn in well-researched and optimally new content for you, with which you can advance the best academic experience. And if any of the writers seem not to have followed the instructions as you would have wanted, you can request free revisions until your heart's content. 99Papers customer review: “The best essay writers!” - “I'm so happy to have encountered this writer. I'm beyond impressed with the thoroughness of his/her work. Thank you so much. There are a couple of writers that I usually request but this writer surpasses any other that I've seen. This writer is at the top. From a customer perspective, I can tell you that I feel 100% comfortable leaving an assignment to this writer and he/she will return superior work without multiple revisions or the stress of missing my deadlines. Thank you.” - Eveline K. #3. PaperCoach PaperCoach is one of the best assignment help websites in Melbourne, Australia by the quality of papers they turn in on their orders. And guess what? The type of paper does not determine their constraints of reach. They deal in all forms of essays and papers that you can think of. These assignments could be of any academic level. It could be a high school essay or a postgraduate essay. By and large, they are available to take on assignments like coursework, case study, creative writing, argumentative essay, literature review, thesis, etc. Their reach of writing also works with resumes, cover letters, term papers, theses, thesis proposals, thesis statements, admission essays, annotated bibliographies, application letters, argumentative essays, articles, article reviews, biography, book review, business plan, case study, coursework, dissertation, dissertation abstract, dissertation chapter, dissertation conclusion, dissertation hypothesis, dissertation introduction, dissertation methodology, etc. Further, PaperCoach has exceptional customer care. Their support team is always on edge to help their customers with any hitches experienced on the platform. They are ready to help you with little or no delay. And guess what? They are available 24/7 for you. So you can reach them at any time that you need to. You might need their services, especially if you are a first-time customer on their platform. They are keen to put you through how their service works and the kind of writing help you could get on their sites. Also, if you have questions that are not readily answered in the FAQs section, they are more than happy to help you with answers. Also, their pricing is quite fair in the market. You don't have to break the bank before you can order from them. With as low as $7.99, you can order a one-paged essay from them. An average 5-page essay with a deadline of up to 7 days will cost you about $60. And this is a very low price compared to most of the other offers you would interact with in the essay writing space. So if you are looking for an online assignment platform that would not bore a hole in your wallet, then you should definitely check PaperHelp out. PaperCoach customer review: Impressed - “I was really impressed with the level of service I received from this paper writing service. The authors are very responsive. They clearly understood my requirements and communicated with me 24/7 to make sure I was getting what I needed. I would definitely recommend this service to anyone who needs help with their writing.” - Leo H. #4. MyAssignmentHelp MyAssignmentHelp has been referred to by many as an indispensable assistant. So, for students in Australia, it is that expert platform that exists to ease the burden of academic pressure they might be facing at a given moment. They are ready to write all your assignments, irrespective of your field of study. And their deliveries are always of the highest quality that you expect. The reason for this is not far-fetched. With over a decade of being functional, a company like this would have fine-tuned its essay abilities. And that they have done, alongside distilling the preferences and needs of their customers very well. On their website, they have laudable services that you can order. The wide range of these assignments and essays makes many students rush to them. These services include essays, dissertations, assignments, coursework, research, thesis, proofreading, and plagiarism check. And even though they can write a lot of papers for you, the quality of these essays is intact. They maintain the top-notch quality on all their deliveries. And accompanying that are prompt deliveries. It also matters that their assignments are not plagiarized. They are freshly written from scratch just for you. And they also follow your paper instructions effectively. With a plethora of positive reviews, feedback, and comments, MyAssignmentHelp has proven itself as one of the stand-out platforms to order essays at relative market prices. For example, with $11, you would get a well-written 1-page essay. However, some extra factors or features of your order specifications might add to the price at checkout. And they include the shortness of the deadline, the type of writer, add-ons such as plagiarism reports, etc. Also, the academic difficulty level of the assignment you are ordering could trigger a jerk-up of the essay price. However, you could also get cash clashes when ordering from them in some special circumstances. That is, up to 10% off. If you are also looking to ask questions of any kind, you can reach out to their customer support. Their customer care team handles all forms of inquiries that you might have about the status of your order or your advantages as a first-time customer on their platform. Also, if you want full detail on how the platform works in general, you can reach out to them via the lines available, and they will respond promptly with all the information you need. MyAssignmentHelp customer review: “It was a professional work, the expert met my expectation, he answered all questions in good and expertise manner. Thank you.” - Martin F. #5. HomeworkForMe If you are in Australia and are wondering where to get the best research in little or no time, then you have found the best place. Company located in Sydney. HomeworkForMe is the reservoir of amazing college paper writers with stunning writing acumen for students from Australia. They are always ready to deploy their mental machinery for your advantage in your academic pursuits. For them, writing is not something they have to stress about doing. They are quite familiar with that world. Many of them are members of the academia themselves and are graduates from reputable universities all over the world. Thus, they have been through your current phase as an undergrad and postgraduate student. And they are always ready to help you with everything you need to ace your studies as a student in any field of study. HomeworkForMe has a wide range of writing needs that they meet. If you want a reliable online assignment help platform that can get the job done irrespective of the type of paper you bring to them, then HomeworkForMe is your go-to place. They work on tasks like term papers, research papers, dissertations, coursework, proofreading, exam notes, short essays, and much more. And these forms of assignments are well-made by the writers on this platform. If you order from Ivory search, you can rest assured that your order will be promptly delivered. That is, the deadline would be well respected. Also, you can expect content written from scratch and void of plagiarism. Yes, they are that good. It's no surprise many students in the dilemma of who calls for 'my assignment help' choose this platform repeatedly. Further, many students and customers keep returning to this website because they are super effective as far as customer support is concerned. There is no time of day you reach out to the customer care team to lodge a complaint or inquire that you would not have anyone to attend to you. Many reviews online are littered with the feature of a remarkable customer care team. Their support team members are regarded as respectful, professional, and keen to answer every question with the necessary information. You might even think you were interacting directly with the HomeworkForMe management. If you have questions about the pricing, then know it is valid. With $9, you can get a decent and well-written essay that comes with the full package of the HomeworkForMe assignment help company. HomeworkForMe customer review: “Thanks a lot to the guys for such help!” - “For the summer in college I was given a big test paper. I realized that I wouldn't be able to do some of it on my own, so I didn't want to procrastinate and sent it to this service to be solved. I had enough time, and I immediately told the manager that there was no hurry. Nevertheless, the work was done very quickly, with high quality, and everything was nice and clearly laid out. Thanks a lot to the guys for such help!” Frequently Asked Questions What is an assignment help? Assignment help means getting assistance on any papers you are asked to work on in school. Sometimes, you need help to work on these assignments yourself. Thus, getting professional help on your essays is a good solution to this challenge you have at hand. Thus, reaching out to these expert writers on a reliable platform is requesting assignment help. It is a defense and an initial approach, depending on what you want it to be. For example, if you have certain constraints that hinder you from giving the assignment everything it takes, assignment help can be a defense against failure in your studies. In the same vein, your first response once you get the essay could be to give it to expert writing specialists to work on it to reach optimal grading with your teacher. Further, assignment help refers to seeing from the perspective of people who have been in your field long before you started your academic pursuits there. Most of the writers who will work on your order on these platforms are academic professionals. Thus, they can give your work a rich touch of perspective and experience. And that would be a great feature in your assignment. What Is the best assignment help provider in Australia? PaperHelp ranks high as the solution to most students' challenges in Australia today. They are the best assignment help provider in the nation. Thus, if you are schooling in this region and need a platform for sorting "my assignment help", get ready to reach out to them. What makes them stand out are numerous. However, topping the list must be the excellence of their work. Once you order any paper from them, irrespective of the field and academic difficulty of the essay, they can deliver original and plagiarism-free content for you with which you can reach great heights in your studies. Further, PaperHelp has great pricing compared to many other online services. For example, with just $10, you can enjoy their service's benefits on normal essays. But a few add-ons could spike the price tag before you checkout. Some of them include the short time frame of the submission deadline, the academic level of the assignment, the extras in the order specifications such as the plagiarism reports, etc. And suppose you need clarification on something on their website. In that case, you can inquire from their customer support, who is available 24/7. What is the best assignment help website from Sydney? If you are in Sydney and need clarification on the best assignment help website, then reach out to HomeworkForMe. They can get your assignment down for you well and fast. They are the platform from Sydney that has serviced many students from across the globe. And with thousands of positive reviews screaming their praise on the internet, you have a safe landing with them as you order. Furthermore, they give you a valid reason to get your assignment done with them in the stellar nature of the content delivered and the swiftness of the delivery. They have a wide array of writing service lines that they tend to. That is, term papers, research papers, course works, dissertations, theses, and even short essays are welcomed by high schoolers. And you must understand their structure. Ordering from them is via their website, with a price calculator. As you select the specifications of your order, more details on its checkout will begin to pop up and add up. Thus, you can use any payment channels specified on the website to make your order and get your work delivered to you in no time. The last essay you can get goes for $9.95 on their platform. Is assignment help legal in Australia? Yes, assignment help is legal in Australia. It is simply just like asking for help naturally. If you are about to fall, you ask for the help of a nearby person to lift you. If you want water, you can ask a nearby friend for water. And sometimes, you pay people for their help, especially if it is professional. You cannot appear in court for yourself, for instance. It mostly requires professional help. And you have to hire the services of a legal expert to help you with them. And well, you pay them. It works the same way as requests for professional help. If you need help with your assignment or essay, or paper, make sure to ask people who are experienced enough to get the job done well. And in this case, they are the services listed above for you to peruse. They are professional assignment help websites for you to get expert writers that combine their rich academic experience and writing expertise to your advantage. Is it cheating to get help on an assignment? No, it is not cheating to get help on an assignment. Why? Simply because getting help is not cheating. It is realizing the need for assistance from a third party or someone other than yourself. And it could come as a result of several reasons. First, many people ask for professional help because they cannot write well in English. Imagine an international student who came to study in Australia but does not have a good command of the native English language. How will he fare when given the assignment to be written all through in the English language? If he attempts such work, he could fail because he would be appraised on grammar and sentential coherence. And that would have long-term repercussions for his academic pursuits. Thus, it is important that he asks for help when he needs it. Also, sometimes, you are just pressed for time on an assignment to complete it with the required research quality. Only an expert could get that done. So, what do you do in that scenario? You ask for help. So, no, getting help on an assignment is not cheating. Can professors tell if you cheat online? No, professors cannot always tell if you cheat online. Mostly because if you get assignment help online from the above-listed websites, you are not cheating. Also, the professor cannot find out that you got external help from them. The only way the professor can likely pick that up is if you got your essay written by a quack or unreliable website. And that can be very dangerous for you. Plus, it has a slim chance of happening to you if you order your essays from the websites we have curated for you above. Further, these websites have a discretion policy where they keep their clients anonymous from the prying eyes of many people over the internet. So, if you have inputted your details on their website, you can keep your mind at rest because it will not be displayed anywhere. That is, you would not find it randomly on any visible or dark website on the internet. How do people get caught up on assignments? There are many ways people get caught on an assignment. And it starts with not ordering from the right websites. If you buy your essay from fake websites on the internet or from quack writing professionals, then you are bound to be a victim. This is because most of the content or assignments these guys would deliver to you would be fake. And they would be ridden with plagiarism. Thus, they are unreliable. And you can easily get caught up on assignments that way. Further, you can also get caught up on an assignment through plagiarism checkers stuck as Turnitin. And with software like that, badly written content hardly get past. So, if you have badly written content from a random stranger or unverified website online, then your essay will most likely be flagged by your professor and the plagiarism-checking tool. But this can be avoided if you choose from the websites noted above for your assignment help needs. They are reliable, and they provide you with 100% plagiarism-free content that you can use and not be flagged by. How to hire an expert and get professional assignment online? The simplest way is by choosing any of the websites we have shared above. You could pick from PaperHelp to 99Papers. Or even opt for HomeworkForMe. There are also other options like PaperCoach. All these platforms are reliable and help you to make the best possible decisions for your assignments. They are great places to visit for my assignments help if you are in Australia. They are reputable and trusted sources of the best essays in the market. And they also provide you with the best possible content in delivery out there. Did we also mention that they turn in the work speedily? So, you should definitely leverage them. These reliable websites have a common attribute that helps keep your heart at rest when you order from them. This is their remarkable customer support. You are never left hanging when you buy your assignment from them. They help you every step of the way. They have their customer care team ready to handle all your reviews, questions, and feedback. Also, if you want to keep tabs on the project you are doing with them, they are always ready to help you with that. Not only so, but the personnel are also respectful and armed with all the relevant information you need to put your heart at rest on every order. Conclusion Life was not designed to be lived alone. You are meant to cohabit and live in a social cluster. If you need help or assistance on anything, you can get the needed scratch on the back. And in the same vein, if anyone else needs your help in the circle, you can be readily available for their assistance. This is the natural exchange of value between humans. And in this case, your academic pursuits cannot be affected because you are unable to work on your assignment. There is online assignment help for you with all the websites we have noted for you above. So, don't look far for help if you are in Australia. Reach out to them today and take your studies to the next level! Contact Details Assignment Solutions Eric Blout eric.blout@myassignment.shop

December 10, 2022 02:55 AM Eastern Standard Time

Article thumbnail News Release

United Network for Organ Sharing Seeks Better Air Transportation for Lifesaving Organs

United Network for Organ Sharing

United Network for Organ Sharing (UNOS), the non-profit that serves as the Organ Procurement and Transplantation Network (OPTN) under contract with the federal government, is seeking to systematically improve nationwide transportation for donated organs. In a letter sent today to U.S. Department of Transportation (DOT) Secretary Pete Buttigieg, UNOS leadership requested a meeting with the DOT as well as the Health Resources and Services Administration (HRSA), the Federal Aviation Administration (FAA) and the Transportation Security Administration (TSA) to discuss potential solutions for increasing efficiency for commercial air transportation of organs for transplant. The letter was authored by UNOS’ Interim CEO Dr. Maureen McBride, UNOS Board President Dr. Jerry McCauley, Vice President/President-Elect Dr. Dianne LaPointe Rudow, and Past President Dr. Matt Cooper. “Practical, logistical, and regulatory obstacles to the safe and efficient delivery of donor organs should be identified, remedied, and monitored,” wrote McBride, McCauley, Rudow and Cooper. “We believe you, the FAA and TSA could provide valuable assistance on how to increase the efficiency of commercial air transportation of organs for transplant.” During an OPTN Board of Directors meeting on Monday, December 5, Dr. McBride called for stakeholders across the donation and transplant community to help expand upon ongoing improvements to the national system, which included prioritizing potential solutions for safer and more efficient organ transportation. “Today we’re going to have a collaborative conversation about how the community can answer the public’s call for assurances that these precious gifts of life are delivered safely and efficiently to their destination,” said Dr. McBride to the OPTN board on Monday. “We’re going to ask all of you to prioritize potential solutions for how the OPTN can fix these problems. That includes advocating as a community for federal level solutions.” Also copied on the letter were HRSA Administrator Carole Johnson, FAA Acting Administrator Billy Nolen, Department of Homeland Security Secretary Alejandro Mayorkas and TSA Administrator David P. Pekoske. A copy of the full letter can be found here. About UNOS United Network for Organ Sharing (UNOS) is a non-profit, charitable organization that serves as the Organ Procurement and Transplantation Network (OPTN) under contract with the federal government. The OPTN helps create and define organ allocation and distribution policies that make the best use of donated organs. This process involves continuously evaluating new advances and discoveries so policies can be adapted to best serve patients waiting for transplants. All transplant programs and organ procurement organizations throughout the country are OPTN members and are obligated to follow the policies the OPTN creates for allocating organs. Contact Details Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

December 08, 2022 03:10 PM Eastern Standard Time

Article thumbnail Digital Asset Direct

Empower Clinics and Specialty Network of North America to bring services to underserved communities

Empower Clinics Inc.

Contact Details Proactive Investors Canada Proactive Studio +1 604-688-8158 na-editorial@proactiveinvestors.com Company Website https://www.proactiveinvestors.ca/

December 08, 2022 08:44 AM Pacific Standard Time

Video
Article thumbnail News Release

Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed

Sunshine Biopharma Inc.

Read the latest report on Sunshine Biopharma here. Protests have mounted in intensity across China in the past weeks, as more and more citizens become frustrated with the country’s radical “Zero-Covid” policies. This was part of the cause for the markets having a rocky opening last week, with Tesla, Inc. (NASDAQ: TSLA) and Apple, Inc. (NASDAQ: AAPL) stock falling and a widespread drop in the oil sector in response to the continuing instability. This uncertainty is a reminder that, even as some describe living with the virus as a ‘new normal,’ complacency toward Covid carries risks. Clearly, there is a need for more effective solutions. Sunshine Biopharma, Inc. (NASDAQ: SBFM) is a Canada-based pharmaceutical company combating COVID-19 through the development of SBFM-PL4, an antiviral treatment. It believes this drug, which it anticipates could be taken in tablet form from home, could be the kill shot for COVID and could help finally put an end to the pandemic. Partnering With The University of Arizona University For Covid Research A fully integrated pharmaceutical company, Sunshine Biopharma specializes in the research and development (R&D) of oncological and antiviral treatments and has multiple ongoing development projects, including SBFM-PL4. The strong team at Sunshine recently started a collaboration with the University of Arizona. Led by Dr. Gregory Thatcher, the collaboration will continue research into SBFM-PL4, and involve testing PLpro inhibitors to see how the drug reacts with the immune system. While companies like Pfizer (NYSE: PFE), Eli Lilly and Co. (NYSE: LLY), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) have developed treatments for COVID, concerns around these drugs range from their limited efficacy to questions around their safety and drug resistance. Meanwhile, Sunshine’s drug targets nsp3 protease, the enzyme which suppresses the patient’s immune system and allows the Covid virions to effect maximal damage. As an nsp3 protease inhibitor, SBFM-PL4 doesn’t merely weaken the virus, like other treatments, but also supports overall health by allowing the patient’s immune system to fight back. The company is confident that, in a Covid-19 vaccine market worth $13.6 billion, its drug candidate could provide a welcome solution. “It is urgent that effective treatments and more specific vaccines be developed at an accelerated pace,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are delighted to be working with Dr. Gregory Thatcher, who is aiming to find a wide array of inhibitors for PLpro (also called nsp3), as this virus-encoded protease is responsible for the suppression of the human immune system.” Along with this important collaboration, Sunshine Biopharma can reflect proudly on a year that saw the company report growth in its financial position and a recent acquisition that may help the company enter the generic prescription drug market and become profitable. It is also developing a drug – Adva-27a – which it believes will be successful in treating various forms of multidrug-resistant cancer. In addition, the company is developing a vaccine-like mRNA treatment for cancer. Want to learn more about Sunshine Biopharma? Visit its website. In addition to working with the University of Arizona on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University’s Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is also engaged in the development of a novel anticancer mRNA called K1.1. The data collected to date have shown that K1.1 mRNA is capable of destroying cancer cells in vitro including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). Studies using non-transformed (normal) human cells (HMEC) have shown that K1.1 mRNA had little or no cytotoxic effects. K1.1 mRNA is readily adaptable for delivery into patients using the proven mRNA vaccine technology. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Christine Petraglia - TraDigital IR +1 917-633-8980 investors@sunshinebiopharma.com Company Website https://sunshinebiopharma.com/

December 08, 2022 09:25 AM Eastern Standard Time

Article thumbnail Digital Asset Direct

MGC Pharmaceuticals delivers its largest-ever order

MGC Pharmaceuticals Ltd

Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 08, 2022 08:46 AM Eastern Standard Time

Video
Article thumbnail News Release

AiViva Says Its AIV001 Shows Potential Promise To Treat Post-Surgical Incisional Scarring And Keloids

AiViva BioPharma

Interested in investing in AiViva’s campaign? Click here to get started! Scarring can have negative physical, aesthetic, and psychological effects if left untreated. A growing awareness of treatment options and technological advancements has given its treatment industry adoption a boost. Scars result from injuries, surgeries, illness, burns and acne. Scars form on your skin or inside your body when one heals an injury or trauma. Our body’s wound healing process can cause the overproduction of collagen, a protein found in the dermis or second layer of the skin, resulting in raised lumpy scarring or keloids. Keloids tend to grow larger over time and in some cases, reappear after treatment. A scar never completely goes away. When it comes to scarring, where it occurs matters. A wound in an area that moves, like your elbow and knee, is more likely to scar. A scar on the face would be harder to heal because one’s face is constantly exposed to the environment. The Growing Market For Scar and Keloid Treatments The keloid and scar treatment market is burgeoning. One reason for this could be an increasing number of accidents, surgeries, and other injuries around the world each year. The combined hypertrophic and keloid scar treatment global market was valued at $6.34 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 8.47% from 2022 to 2030. Companies like Sanoma Pharmaceuticals (NASDAQ: SNOA) are partnering with e-commerce sites like Amazon.com Inc. (NASDAQ: AMZN) to provide hypertrophic and keloid scar treatment products in the U.S. Partnerships like this are also expected to drive the retail pharmacy segment. There are reportedly no approved drugs on the market for the prevention of scars following surgery. The appearance of scar may be improved by laser therapy, steroid injections, or silicon sheets. Dermatologists and plastic surgeons may surgically remove a scar to restore function of a body part that may have been restricted by the scar. Keloid scars are difficult to get rid of and tend to return after treatment in a majority of cases. Current treatments for keloids include steroidal injections at the scar site, cryosurgery (freezing), keloidectomy (surgical removal), pressure dressings, silicone sheeting and gels and radiation. While each of these treatment options by themselves, or when combined with others, could help by treating and improving physical appearance and skin sensitivity issues such as itch and pain, a scar never goes away. How AiViva’s AIV001 Treatment Could Address Scar Formation AIV001 is a compound that could address the negative impacts of scarring. AIV001 has been found to be effective in modulating inflammation and scarring of the skin as well as reducing neovascularization (cell proliferation) associated with some cancers, according to AiViva. The company says it has seen positive signals from its phase I clinical trial of AIV001 for incision-based dermal scarring and wound healing. Trial results showed that AIV001 was safe and well tolerated in the local intradermal treatment of incisional wounds and reduced fibrosis through only a single dose with no systemic side effects observed in humans. These results suggest that the intradermal AIV001 treatment could potentially have significant clinical utility by modulating the aberrant scarring associated with fibrosis during the wound-healing process. “Scarring has been a significant issue that can cause debilitating aesthetic, functional and psychological effects. There are no (Food and Drug Administration) FDA-approved therapeutics for the treatment of post-operative scars, therefore, AIV001 has the potential to be a transformative treatment in this space,” AiViva CEO Diane Tang-Liu said. About AiViva Biopharma: AiViva Biopharma, is a clinical stage biotech company founded in 2015 by four pharmaceutical industry veterans with more than 300 years of combined industry experience. AiViva's founders have demonstrated a successful track record across the full spectrum of drug development and commercialization, in addition to raising capital, and IPOs on the NYSE and NASDAQ.AiViva was formed with the mission of developing novel, innovative pharmaceutical products through an efficient, risk-mitigated development strategy to address major unmet medical needs. The company has raised over $30 million in capital so far, including over $10 million raised in 2022. AiViva was rated as a top 20 clinical-stage biopharma company by Life Sciences Review in 2022. Interested in investing in AiViva? Click here. If you would like to learn more about AiViva, check out its website. AiViva is a clinical stage biotech company which has created proprietary technology and new treatments to address significant, unmet medical needs in ophthalmology, dermatology, urology, and oncology. The company is led by a team of seasoned industry experts who have an outstanding track record in successful drug development, commercialization, and multiple IPOs on the NYSE and NASDAQ. The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17(b) disclosure linked in the campaign page for more information. Contact Details Michael office@aiviva.com Company Website https://aiviva.com/

December 08, 2022 08:00 AM Eastern Standard Time

Article thumbnail News Release

Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive

Unicycive Therapeautics, Inc.

In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount to providers of dialysis services. In October, the CMS published its “Final Rule” updating payment rates and policies for the PPS for end-stage renal disease (ESRD), for the calendar year 2023. The ESRD PPS, often referred to as “the bundle”, is the government-funded program that pays for renal dialysis services and certain prescription drugs for patients with late-stage chronic kidney disease (CKD). A category of drugs called phosphate binders that dialysis patients need to be able to control a severe complication of their disease known as hyperphosphatemia is currently not covered under the ESRD PPS. Therefore, dialysis patients currently resort to sourcing their phosphate binders through prescription drug plans run by for-profit insurance companies, a process which is fraught with challenges due to these branded prescriptions being more expensive and difficult to access. In the 2023 Final Rule, the CMS commented on its intention to include phosphate binders in the bundle, stating that the addition of phosphate binders would “mitigate the risk of potential access issues for minority populations, which include African-American/Black, Asian, Hispanic, and Other non-white populations, promote health equity for patients that lack Medicare Part D coverage or have coverage less generous than the Part D standard benefit, and contribute to better clinical outcomes by leveling the playing field for all patients with ESRD”. This change is slated to be implemented in 2025 through the TDAPA (transitional drug add-on payment adjustment) –- a direct government payment program that takes the reimbursement process out of the hands of private insurance companies. During a minimum 2-year TDAPA period starting in 2025, CMS will evaluate the additional cost of adding phosphate binders into the PPS “bundle” and then make the change permanent. CMS’s goal in this planned change to phosphate binder reimbursement is to “result in better drug therapy management for the ESRD beneficiary, and to improve their access to these medications”. This development could be great news for Unicycive Therapeutics Inc. (NASDAQ: UNCY). The company is developing what they believe to be a best-in-class phosphate binder they hope to get approved by the FDA in 2024. The company is developing an investigational new drug called Renazorb TM (lanthanum dioxycarbonate that binds and eliminates phosphate in the gastrointestinal tract. Renazorb utilizes a proprietary nanoparticle technology being developed by Unicycive for the treatment of hyperphosphatemia in CKD patients on dialysis. Unicycive says that it has completed a clinical trial studying Renazorb in 32 healthy volunteers with encouraging results – as per the study Renazorb was minimally absorbed into the systemic circulation and was safe and well-tolerated at doses up to 6000 mg/day. Renazorb was found to significantly reduce urine phosphate excretion and significantly increase fecal phosphate excretion at doses at and above 3000 mg/day. The company says that Renazorb offers potential advantages over the most commonly used phosphate binder – Renvela – because it dramatically reduces the number and size of pills that patients are required to take. Many people suffering from CKD are weighed down by a high pill burden due to their various other comorbidities that require taking multiple pills. This leads to patients neglecting to take their medication because they are overwhelmed by the number and size of the pills they must take. Unicycle says that the efficiency and smaller size of Renazorb pills could reduce the pill burden for these patients by 3 to 4 fold. Renazorb also has an added convenience for patients since it is swallowed with water instead of having to be chewed. Renazorb is protected by patents in the U.S. and other countries outside the U.S. including Canada, Europe, Japan, China, and Australia, with validity until 2031. “Gaining early patient access and reimbursement for newly launched branded drugs can be a challenge” stated Doug Jermasek, Executive Vice President at Unicycive. “For-profit insurance plans often restrict access to new drugs or impose very high patient copays. Beginning in 2025, and coinciding with the expected launch of our promising new medicine, these barriers will be removed for patients and their healthcare providers. We are excited by the potential to launch RENAZORB into this new environment of expanded patient access.” Unicycive is also developing a drug for the treatment of acute kidney injury – namely UNI 494 – for which the company is filing to begin Phase 1 human trials. Other companies developing drugs for the treatment of CKD include Ardelyx Inc. (NASDAQ: ARDX), Akebia Therapeutics Inc. (NASDAQ: AKBA), and Cara Therapeutics. ( NASDAQ: CARA). To learn more about Unicycive visit its website. Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent-protected new chemical entity in late preclinical development for the treatment of acute kidney injury. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Anne Marie Fields - Stern Investor Relations +1 212-362-1200 annemarie.fields@sternir.com Company Website https://unicycive.com/

December 08, 2022 08:00 AM Eastern Standard Time

Article thumbnail News Release

'Tis the Season-ally Inspired Holiday Menus at Firebirds Wood Fired Grill

500NewsWire

Charlotte, NC ( 500NewsWire ) -- Firebirds Wood Fired Grill introduces new holiday lunch and dinner menus just in time to make any celebration a memorable one this holiday season. From hand-cut wood-fire grilled NY Strip, and certified Duroc pork chop with cognac cream sauce, to Bananas Foster Bread Pudding for dessert, Firebirds’ limited time scratch-made menus are available now through January 3. Firebirds Wood Fired Grill is known for its signature hand-cut steaks and fresh seafood hand-fileted in-house and seared over locally sourced hickory, oak, or pecan wood on Firebirds’ exposed wood-fired grill. Firebirds’ seasonal Lunch Menu includes suggested wine pairings, and features: NY Strip (10oz.) BLT butter / choice of side Suggested wine pairing: Decoy Cabernet Sauvignon Parmesan Crusted Mahi Coal-roasted tomato-basil sauce / “loaded “ember-grilled corn / fresh asparagus Suggested wine pairing: Decoy Chardonnay Lump Crab Cakes Bold remoulade / wonton slaw / seasoned steak fries Suggested wine pairing: Firebirds Private Label Chardonnay Guests can enhance their entrées by adding: Lump Crab Cake Lobster Mac & Cheese Dessert Bananas Foster Bread Pudding Vanilla bean ice cream / spiced pecans / crispy cinnamon-sugar tortilla Firebirds’ seasonal Dinner Menu includes suggested wine pairings, and features: NY Strip (14oz.) BLT butter / choice of side Suggested wine pairing: Decoy Cabernet Sauvignon Tomahawk Prime Pork Chop Wood-grilled, certified Duroc pork chop / cognac cream sauce / red wine-poached apples / green chile mac & cheese Suggested wine pairing: Acrobat Pinot Noir Parmesan Crusted Mahi Coal-roasted tomato-basil sauce / “loaded “ember-grilled corn / fresh asparagus Suggested wine pairing: Decoy Chardonnay Lump Crab Cakes Bold remoulade / wonton slaw / seasoned steak fries Suggested wine pairing: Firebirds Private Label Chardonnay Guests can enhance their entrees by adding: Lump Crab Cake Lobster Mac & Cheese Dessert Bananas Foster Bread Pudding Vanilla bean ice cream / spiced pecans / crispy cinnamon-sugar tortilla Many of the restaurant’s dishes are created using fresh seasonal ingredients. Gluten-sensitive menu items, such as Grilled Tenderloin Salad, Wood Grilled Salmon, and Parmesan Mashed Potatoes, are also available. Firebirds offers catering, online ordering for ToGo and delivery options. In addition, Firebirds is offering a holiday gift card promotion. For every $100 in gift cards purchased in-store or online, guests will receive $20 in “bonus cards.” This special offer is available now through December 31st and “bonus cards” are valid for redemption from January 1 through February 9, 2023. For more information visit firebirdsrestaurants.com/gift-cards/. Firebirds Wood Fired Grill’s FIREBAR® offers an impressive array of seasonal cocktails, craft beer, bourbon, after-dinner drinks, Firebirds’ private label wine, hand crafted mocktails and more. Popular specialties include Wine Down Mondays, and happy hour in the FIREBAR® and on the Patio every Monday through Friday from 4PM – 7PM. Happy Hour times vary. Visit FirebirdsRestaurants.com to make a reservation, order ToGo online, or register to become a member of Firebirds’ Inner Circle and be the first to hear about upcoming events, promotions, new menu items and exclusive offers. Members receive a gift for joining and a gift for their birthday. About Firebirds Wood Fired Grill Firebirds Wood Fired Grill, a polished casual American restaurant, is an energetic twist on the traditional grill featuring a boldly flavored menu in a stylish, fire-centric atmosphere. Signature menu items include hand-cut steaks and fresh seafood hand-fileted in-house and seared over locally sourced hickory, oak, or pecan wood on Firebirds’ exposed wood-fired grill. Complementing its inviting dining room, a patio with seasonal comforts and the award-winning FIREBAR® are additional gathering spaces inside the restaurant. Firebirds has been named one of ten ‘Breakout Brands’ by Nation’s Restaurant News, and the 2022 Diners’ Choice Winner awarded by OpenTable. Firebirds supports sustainability efforts and partners with Alex’s Lemonade Stand Foundation, having surpassed $3 million raised for childhood cancer research through the sale of fresh-squeezed lemonade. To become a member of Firebirds Inner Circle, order ToGo online or to make a reservation visit firebirdsrestaurants.com. Contact Details Firebirds Wood Fired Grill Lesley Gamwell +1 404-309-6915 lgamwell@rountreegroup.com Company Website https://firebirdsrestaurants.com/

December 07, 2022 08:59 AM Eastern Standard Time

Article thumbnail News Release

A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial

Enlivex Therapeutics, Ltd.

Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced that Israel, Spain and Greece have cleared amendments to the company’s Phase II trial protocol that will allow the study to enroll more patients. The cleared amendments also allow Enlivex to use a newly developed frozen formulation of Allocetra TM — the macrophage reprogramming immunotherapy it’s evaluating as a potential sepsis treatment in the clinical trial. The Current Standard Of Care For Sepsis Needs Improvement Each year, about 1.7 million U.S. adults develop sepsis in response to an infection. Of those, about 350,000 will die from septic shock, according to the Centers for Disease Control (CDC). Despite the risks of sepsis, there is currently no specific treatment for the life-threatening condition. That’s because it’s not a pathogen in its own right but an extreme response to an infection the patient already has. That underlying infection can be bacterial, fungal or viral so treating sepsis often starts with identifying the underlying infection and administering the appropriate antibiotic, antimicrobial or antiviral treatment. This initial treatment, along with intravenous fluids and vasopressors to maintain organ function and blood pressure, forms the current standard of care, but they’re really just a way of keeping the patient alive while their immune system, hopefully, fights the infection causing the sepsis response. Even with this standard of care, timing is everything. In a study of New York State Department of Health data, researchers found that for each hour antibiotic treatment was delayed in patients with sepsis, the risk of mortality increased by 4%. In other words, patients need to receive treatment as soon as possible to increase the odds of survival. This large unmet need has motivated many pharmaceutical companies to explore new treatment options, but so far, few have shown significant promise. For example, monoclonal antibodies (mAbs), like Merck & Co. Inc. ’s (NYSE: MRK) bezlotoxumab or Aridis Pharmaceuticals Inc. ’s (NASDAQ: ARDS) tosatoxumab, have made some headway, but these are engineered to target specific infections. So doctors would need to identify the specific mAb to use and hope that one exists for that particular infection, which is not a guarantee since mAbs are still relatively new. Enlivex’s Allocetra Is An Immunotherapy That Could Rebalance The Immune Response At its core, sepsis is an extreme immune response to an infection in the body. That’s why Enlivex has chosen to explore immunotherapy options for treating the condition. Allocetra TM, it’s leading drug candidate, works by reprogramming macrophages from healthy donor cells to help the patient’s own macrophages return to their homeostatic state of stability. Macrophages are a type of immune cell that circulates throughout the body, monitoring for signs of infection. When a pathogen is spotted, they immediately “eat” it and send out an alarm signal to the rest of the immune system. Certain conditions, like sepsis, can disrupt macrophages, triggering an excessive inflammatory response that can end up causing the organ damage and organ failure that make sepsis so life-threatening. Allocetra’s formula uses donor macrophages that have been programmed to send out an “eat me” signal to the host’s macrophages. Once engulfed, the donor cells then reprogram those host macrophages to return to their homeostatic state. In the preclinical and clinical trials Enlivex has completed so far, that return to homeostasis has resulted in reduced mortality and improved sequential organ failure assessment (SOFA) scores, suggesting that the immunotherapy could help moderate the immune response and protect organs from damage and failure. While antimicrobials will still be necessary for fighting the underlying infection, Allocetra’s ability to influence the host’s overactive immune response could become an essential tool for preventing long-term damage and reducing mortality rates. The Phase II Clinical Trial Will Include An Expanded Patient Population And A More Shelf-Stable Version Of Allocetra Initially, the Phase II trial was limited to patients with pneumonia-associated sepsis. With the recent amendments cleared by Israel, Spain and Greece, Enlivex is now able to expand the trial to include patients with sepsis related to biliary, urinary tract and peritoneal infections. The amendments also clear the way for the clinical-stage immunotherapy company to treat patients in the trial with its newer frozen formulation of Allocetra. In development for the last two years, frozen Allocetra is expected to have a shelf life spanning years rather than the 96-hour shelf life of the liquid version. A longer shelf life means Enlivex can manufacture the novel immunotherapy at scale and hospitals can keep it in stock so that it’s readily available for rapid deployment for the treatment of sepsis patients. Enlivex plans to submit these same protocol amendments in other jurisdictions in hopes of further expanding its Phase II research. But with the regulatory clearance achieved so far, the company is optimistic that it can shorten the timeline to potential approval of frozen Allocetra as a sepsis treatment, which could move up the date of a possible commercial launch. As part of a new generation of companies representing the future of cell therapy – off-the-shelf, highly scalable and low COGS “beyond CAR-T” cell therapies – Enlivex is focused on a highly differentiated novel immunotherapeutic mechanism – macrophage homeostasis. Macrophage homeostasis is severely disrupted by certain diseases states, and such imbalance is critical to the progression of the diseases. Allocetra has the potential to introduce highly-effective, low-cost allogeneic cell therapies for life-threatening clinical indications that are defined as "unmet medical needs", including sepsis – one of the leading causes of mortality, and oncology, through restoration of macrophage homeostasis. Enlivex is led by a seasoned management team who founded PROLOR Biotech and led it to a successful $560 financial exit and a partnership with Pfizer. PROLOR’s lead product, now named NGenla® by Pfizer, recently received marketing approval in Australia, Canada, Japan and the EU. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Safe Harbor Statement: This press release contains forward-looking statements, which may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would”, “could,” “intends,” “estimates,” “suggests,” “has the potential to” and other words of similar meaning, including statements regarding expected cash balances, market opportunities for the results of current clinical studies and preclinical experiments, the effectiveness of, and market opportunities for, ALLOCETRA TM programs. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect Enlivex’s business and prospects, including the risks that Enlivex may not succeed in generating any revenues or developing any commercial products; that the products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the ALLOCETRA TM product line could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in Enlivex’s filings with the Securities and Exchange Commission, including in the Company’s most recent Annual Report on Form 20-F filed with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. Contact Details Shachar Shlosberger shachar@enlivexpharm.com Company Website https://enlivex.com

December 07, 2022 08:40 AM Eastern Standard Time

1 ... 141142143144145 ... 236